Some people do well on GLP-1s and need all the help they can get, and increase doses every four weeks like clockwork until they reach the maximum
Linkage of GLP-1 into elastin-like protein (ELP) polymers that form viscous reservoirs at body temperature and methods for enzyme-controlled release of GLP-1 from reservoirs have also been described but have yet to receive clinical evaluation [44]
Acral vitiliginous lesions, located on the wrist, hand, ankle, and foot, are often resistant to medical therapies, probably due to their lower content of melanocytes and hair follicles, which harbor melanocyte stem cells
dose reduction of sulfonylureas or insulin is usually necessary when initiating a GLP-1 receptor agonist, as advised in the Summary of Product Characteristics (SmPC) for each agent
Fukushima S, Kurganov E, Hiratsuka D, Miyata S
No washout period is needed between the two medications